Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study

Abstract

Background: Previous studies on the influence of HLA-DRB1 alleles on multiple sclerosis (MS) susceptibility and clinical course have mostly employed the 2-point genotyping method.

Objective: To assess the influence of HLA-DRB1 alleles and allele interactions on disease risk and clinical course in a large West Australian MS patient cohort using high-resolution genotyping.

Methods: Four digit HLA-DRB1 genotyping was performed on a group of 466 clinically definite or probable MS patients from the Perth Demyelinating Diseases Database and 189 healthy Caucasian controls from the Busselton Community Health Study.

Results: In addition to the known risk allele HLA-DRB1*1501, evidence of increased susceptibility to MS was found for three additional alleles, DRB1*0405, DRB1*1104 and DRB1*1303, though the power was insufficient to sustain significance for these when crudely Bonferroni corrected over all alleles considered. DRB1*0701 was found to be protective even after correction for multiple comparisons. In addition we found evidence that the DRB1*04 sub-allele HLA-DRB1*0407 and HLA-DRB1*0901 may be protective. Among the diplotypes, the highest estimated risk was in HLA-DRB1*1501/*0801 heterozygotes and DRB1*1501 homozygotes and the lowest in HLA-DRB1*0701/*0101 heterozygotes. There was no significant gender association with HLA-DRB1*1501 overall, but the HLA-DRB1*1501/*1104 risk genotype was significantly associated with female gender. HLA-DRB1*1501 was the strongest risk allele in both primary progressive MS and relapsing—remitting MS.

Conclusion: Our results demonstrate the advantages of high-resolution HLA genotyping in recognizing risk-modifying alleles and allele combinations in this patient cohort and in recognizing the differential effects of HLA-DRB1*04 and DRB1*11 sub-alleles.

Keywords

high-resolution genotype human leukocyte antigen (HLA)multiple sclerosis susceptibility

Get full access to this article

View all access options for this article.

References

Lincoln MR , Montpetit A. , Cader MZ , et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-1112.

Hafler DA , Compston A. , Sawcer S. , et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.

Schmidt H. , Williamson D. , Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 2007; 165: 1097-1109.

Marrosu MG , Murru MR , Costa G. , et al. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998 ; 7: 1235-1237.

Masterman T. , Ligers A. , Olsson T. , et al. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000; 48: 211-219.

Caillier SJ , Briggs F. , Cree BA , et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol 2008; 181: 5473-5480.

Stankovich J. , Butzkueven H. , Marriott M. , et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis . Tissue Antigens 2009; 74: 17-21.

Fernandez O. , R-Antigüedad A. , Pinto-Medel MJ , et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol 2009; [Epub ahead of print].

Ballerini C. , Guerini FR , Rombola G. , et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004; 150: 178-185.

10.

Dyment DA , Herrera BM , Cader MZ , et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005; 14: 2019-2026.

11.

Barcellos LF , Sawcer S. , Ramsay PP , et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15: 2813-2824.

12.

Lincoln MR , Ramagopalan SV , Chao MJ , et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2009; 106: 7542-7547.

13.

Chao MJ , Barnardo MC , Lincoln MR , et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2008; 105: 13069-13074.

14.

Ramagopalan SV , Ebers GC Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology 2009 ; 72: 566-567.

15.

Kwon OJ , Karni A. , Israel S. , et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol 1999; 56: 555-560.

16.

Marrosu MG , Murru R. , Murru MR , et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001; 10: 2907-2916.

17.

Listgarten J. , Brumme Z. , Kadie C. , et al. Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol 2008; 4: e1000016.

18.

Svejgaard A. The immunogenetics of multiple sclerosis. Immunogenetics 2008; 60: 275-286.

19.

Wu JS , Zhang MN , Carroll WM , et al. Characterisation of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry 2008; 79: 1022-1026.

20.

Poser CM , Paty DW , Scheinberg L. , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983 ; 13: 227-231.

21.

Compston A. , Edan G. , Goodkin D. , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001; 50: 121-127.

22.

Welborn TA The Busselton Study: mapping population health. Cardiovascular and respiratory disease risk factors in Busselton, Australia. Sydney: Australasian Medical Publishing Company, 1998.

23.

Sayer D. , Whidborne R. , Brestovac B. , et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 2001; 57: 46-54.

24.

Roxburgh RH , Seaman SR , Masterman T. , et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.

25.

Ramagopalan SV , Herrera BM , Bell JT , et al. Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet 2008; 122: 661-663.

26.

Hensiek AE , Sawcer SJ , Feakes R. , et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72: 184-187.

27.

Wu JS , Qiu W. , Castley A. , et al. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia. Mult Scler 2009; 16: 15-20.